Epanutin (phenytoin) 30mg/5ml oral suspension supply disruption

The Department of Health and Social Care (DHSC) has advised that Pfizer expect that Epanutin (phenytoin) 30mg/5ml oral suspension will be out of stock from w/c 10th June for 6-8 weeks. 

The Canadian brand of Epanutin® ‘Dilantin-30’ is equivalent to Epanutin 30mg/5ml oral suspension and supplies are available on an ‘unlicensed’ basis.

Different formulations of phenytoin (other than Dilantin 30mg/5ml oral suspension) are not interchangeable and if patients are switched to anything other than ‘Dilantin (phenytoin) 30mg/5ml oral suspension’ careful management of switching and monitoring is required. 

Further details of the supply disruption and actions to be taken can be found here.

Further information:
Letter from Pfizer 
Epanutin PIL and SPC
Dilantin PIL and monograph